On this episode of IoT Time Podcast, Ken Briodagh sits down with Judy Murrah, CIO, Applied DNA Sciences, to talk about how companies can use DNA tags for asset tracking, forensic testing and all sorts of other Supply Chain enhancements and efficiencies.
Applied DNA Announces Selected Preliminary Unaudited Fiscal 2018 Year End and Fourth Quarter Financial Results
STONY BROOK, N.Y. – December 13, 2018 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in large-scale PCR-based DNA manufacturing, announced selected preliminary unaudited financial results for the full fiscal year and quarter ended September 30, 2018. Preliminary (Unaudited) Fiscal 2018 Financial Results: Revenues for fiscal 2018 totaled $3.9 [...]
Applied DNA Signs Joint Development Agreement with Everledger to Develop and Market a CertainT®-Enhanced, Blockchain-Based Platform for Provenance Verification
STONY BROOK N.Y., December 10, 2018 – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA,” “the Company”), a leader in large-scale PCR-based DNA manufacturing, announced today the signing of a Joint Development Agreement (the “Agreement”) with Everledger, Inc. (“Everledger”), an independent emerging technology enterprise. Under the Agreement the parties will develop and [...]
STONY BROOK, N.Y., December 6, 2018 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA,” the “Company”), the leader in large-scale PCR-based DNA manufacturing, today announced that Dr. James Hayward, president & CEO, will present at the Long Island Capital Alliance’s Cannabis Capital Forum (the “Forum”) in Melville, N.Y., on Friday, December 7 at 9:00 [...]
LineaRx to Hold Analyst Day Webinar to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
STONY BROOK N.Y., December 4, 2018 – LineaRx, Inc., the biotherapeutics company based on the use of large-scale production of gene-sized DNA by Polymerase Chain Reaction (“PCR”) and dedicated to revolutionizing biotherapeutics for the masses in affordability, availability, time-to-market, and reducing the risk associated with virally mediated therapy, and a wholly-owned subsidiary [...]
In-Pharma Technologist | An easy pill to swallow: Colorcon tech targets the old, young, and pill-fatigued
26-Nov-2018 By Flora Southey Swallowability is a recognised and growing patient problem, according to Colorcon’s general manager of film coatings, Kelly Boyer.
STONY BROOK N.Y., November 26, 2018 – Applied DNA Sciences Inc. (NASDAQ: APDN, “Applied DNA,” “the Company”), the leader in large-scale PCR-based DNA manufacturing, is pleased to report that SigNature DNA evidence has resulted in over 131 convictions, with sentences of 625 years to date, and many more cases in the pipeline. [...]
Applied DNA, a leader in large-scale PCR-based DNA manufacturing, has signed a collaboration agreement with Eurofins BLC to support commercial implementation of Applied DNA’s SigNature T-based leather traceability system. The signing of the agreement follows successful completion of the funded consortium research project with BLC as announced in May 2018. “There is a strong need [...]
Brands and retailers sourcing leather for their products are a step closer to being more equipped to trace the raw material through their supply chains.